Suppr超能文献

治疗与未治疗的放射性视网膜病变的长期视力结果(一篇美国眼科学会论文)

Long-term visual acuity results of treated and untreated radiation retinopathy (an AOS thesis).

作者信息

Kinyoun James L

机构信息

Department of Ophthalmology, University of Washington, Seattle, Washington, USA.

出版信息

Trans Am Ophthalmol Soc. 2008;106:325-35.

Abstract

PURPOSE

To report ocular findings in eyes with radiation retinopathy and visual acuity (VA) results of photocoagulation for macular edema and proliferative retinopathy.

METHODS

This retrospective case series compared VA after photocoagulation treatment and nontreatment of radiation macular edema. Visual outcomes were assessed with regression analyses.

RESULTS

Eighty-seven eyes (78 [89.7%] treated with external beam irradiation and 9 treated with local plaques) were studied. Fifty-nine (67.8%) and 28 (32.2%) eyes had nonproliferative and proliferative retinopathy, respectively; macular edema developed in 42 nonproliferative eyes (71.2%) and 24 proliferative eyes (85.7%). Initial VAs (median) were 20/40 and 20/65 for nonproliferative and proliferative eyes, respectively, and final VA was 20/80 and 20/400. Initial VA (median) in eyes with macular edema was 20/50 compared to 20/25 in eyes without edema; final VAs were 20/200 and 20/30. Comparing treated (19 [45.2%]) and untreated (23[54.8%]) macular edema in 42 eyes with nonproliferative retinopathy, initial median VA (20/40 and 20/50) and final VA (20/100 and 20/200) were better in treated eyes. Regression analysis showed significant treatment effect (P = .003) when initial VA (logMAR) and months of follow-up were kept constant; treated eyes had mean final VA (logMAR) 0.36 (95% CI, 0.12-0.60) better than untreated eyes.

CONCLUSIONS

The presence of macular edema and proliferation indicates more severe retinopathy and worse visual prognosis than for eyes without macular edema and proliferation. Although these VA results suggest macular photocoagulation is beneficial, eyes with macular edema continue to lose vision despite treatment. Better prevention and treatment methods are needed for radiation retinopathy.

摘要

目的

报告放射性视网膜病变患者的眼部检查结果,以及黄斑水肿和增殖性视网膜病变的光凝治疗视力(VA)结果。

方法

本回顾性病例系列比较了光凝治疗和未治疗放射性黄斑水肿后的视力。通过回归分析评估视觉结果。

结果

共研究了87只眼(78只[89.7%]接受外照射治疗,9只接受局部敷贴治疗)。59只眼(67.8%)为非增殖性视网膜病变,28只眼(32.2%)为增殖性视网膜病变;42只非增殖性眼(71.2%)和24只增殖性眼(85.7%)出现黄斑水肿。非增殖性和增殖性眼的初始视力(中位数)分别为20/40和20/65,最终视力分别为20/80和20/400。有黄斑水肿的眼初始视力(中位数)为20/50,无水肿的眼为20/25;最终视力分别为20/200和20/30。比较42只非增殖性视网膜病变眼中接受治疗(19只[45.2%])和未接受治疗(23只[54.8%])的黄斑水肿,接受治疗的眼初始中位数视力(20/40和20/50)和最终视力(20/100和20/200)更好。回归分析显示,当初始视力(logMAR)和随访月数保持不变时,治疗效果显著(P = .003);接受治疗的眼最终平均视力(logMAR)比未治疗的眼好0.36(95%CI,0.12 - 0.60)。

结论

与无黄斑水肿和增殖的眼相比,黄斑水肿和增殖的存在表明视网膜病变更严重,视觉预后更差。尽管这些视力结果表明黄斑光凝有益,但黄斑水肿的眼尽管接受了治疗仍继续丧失视力。放射性视网膜病变需要更好的预防和治疗方法。

相似文献

2
Proliferative radiation retinopathy.
Arch Ophthalmol. 1996 Sep;114(9):1097-100. doi: 10.1001/archopht.1996.01100140299007.
9
The variable efficacy of intravitreal bevacizumab and triamcinolone acetonide for cystoid macular edema due to radiation retinopathy.
Semin Ophthalmol. 2015 Jul;30(4):276-80. doi: 10.3109/08820538.2013.847110. Epub 2013 Nov 19.

引用本文的文献

1
Radiation Retinopathy: Microangiopathy-Inflammation-Neurodegeneration.
Cells. 2025 Feb 18;14(4):298. doi: 10.3390/cells14040298.
3
Early anti-VEGF treatment for radiation maculopathy and optic neuropathy: lessons learned.
Eye (Lond). 2023 Apr;37(5):866-874. doi: 10.1038/s41433-022-02200-5. Epub 2022 Aug 16.
4
Two-year results for ranibizumab for radiation retinopathy (RRR): a randomized, prospective trial.
Graefes Arch Clin Exp Ophthalmol. 2022 Jan;260(1):47-54. doi: 10.1007/s00417-021-05281-2. Epub 2021 Aug 31.
6
PAMM and the ischemic cascade associated with radiation retinopathy.
Am J Ophthalmol Case Rep. 2020 Sep 8;20:100918. doi: 10.1016/j.ajoc.2020.100918. eCollection 2020 Dec.
7
Glioma-associated radiation retinopathy treated successfully with aflibercept.
Ther Clin Risk Manag. 2019 Jul 26;15:937-941. doi: 10.2147/TCRM.S204841. eCollection 2019.
8
Pathophysiology of Diabetic Retinopathy: Contribution and Limitations of Laboratory Research.
Ophthalmic Res. 2019;62(4):196-202. doi: 10.1159/000500026. Epub 2019 Jul 30.
9
Radiation Retinopathy 47 Years following Brachytherapy for Retinoblastoma.
Ocul Oncol Pathol. 2018 Apr;4(3):157-160. doi: 10.1159/000481312. Epub 2017 Nov 3.

本文引用的文献

1
RPE transplantation and its role in retinal disease.
Prog Retin Eye Res. 2007 Nov;26(6):598-635. doi: 10.1016/j.preteyeres.2007.07.001. Epub 2007 Jul 25.
2
Visual acuity as an outcome measure in clinical trials of retinal diseases.
Ophthalmology. 2007 Oct;114(10):1804-9. doi: 10.1016/j.ophtha.2007.06.047.
3
Prophylactic cranial irradiation in extensive small-cell lung cancer.
N Engl J Med. 2007 Aug 16;357(7):664-72. doi: 10.1056/NEJMoa071780.
4
A phase II randomized clinical trial of intravitreal bevacizumab for diabetic macular edema.
Ophthalmology. 2007 Oct;114(10):1860-7. doi: 10.1016/j.ophtha.2007.05.062. Epub 2007 Aug 15.
5
Anti-vascular endothelial growth factor bevacizumab (avastin) for radiation retinopathy.
Arch Ophthalmol. 2007 Jun;125(6):751-6. doi: 10.1001/archopht.125.6.751.
6
Visual performance using a retinal prosthesis in three subjects with retinitis pigmentosa.
Am J Ophthalmol. 2007 May;143(5):820-827. doi: 10.1016/j.ajo.2007.01.027. Epub 2007 Mar 23.
9
Intravitreal triamcinolone acetonide for acute radiation papillopathy.
Retina. 2006 May-Jun;26(5):537-44. doi: 10.1097/00006982-200605000-00007.
10

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验